Malignant Transformation of Endometriosis into Endometrioid Ovarian Carcinoma with a Contralateral Borderline Seromucinous Tumour: A Rare Case Report
Case report
OA: gold
CC0
AI-generated summary
This case report describes the rare malignant transformation of endometriosis into endometrioid ovarian carcinoma accompanied by a contralateral borderline seromucinous tumor.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ABSTRACT Background Endometriosis-associated ovarian cancer is uncommon and is most often represented by endometrioid and clear cell carcinomas. Synchronous contralateral borderline ovarian tumours are uncommon and may be missed when gross intraoperative assessment is reassuring. Case A 43-year-old woman with a confirmed diagnosis of endometriosis for approximately 5 years presented with worsening pelvic pain and menstrual symptoms. A left ovarian endometrioma increased from 6.1 × 6.8 × 5.2 cm in April 2024 to 8.8 × 9 × 9.5 cm in April 2025, with subsequent MRI showing a complex mass with solid components (O-RADS MRI 5). CA-125 was 408.6 U/mL and CA 19-9 was 643.58 U/mL; RMI-I was 1225.8 (U=3, M=1, CA-125=408.6). Staging laparotomy was performed. Histopathology demonstrated grade 2 endometrioid adenocarcinoma arising in an endometriotic cyst of the left ovary, FIGO stage IC1, while the grossly normal-appearing right ovary contained a borderline seromucinous tumour with endometrioid differentiation. The omentum, peritoneal cytology, and all 31 sampled lymph nodes were negative for malignancy. Immunohistochemistry supported endometrioid carcinoma. Conclusion This case highlights the importance of interval change and suspicious imaging features in an endometrioma, the limitations of gross intraoperative assessment of the contralateral ovary, and the value of complete histopathological examination in identifying synchronous bilateral ovarian pathology.
My notes (saved in your browser only)
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (10)
- Clinical characteristics of patients in Japan with ovarian cancer presumably arising from ovarian endometrioma via openalex
- Endometriosis-Associated Ovarian Carcinomas: How PI3K/AKT/mTOR Pathway Affects Their Pathogenesis via openalex
- Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets-a narrative review via openalex
- Endometriosis in clear cell and endometrioid carcinoma ovary: its impact on clinicopathological characteristics and survival outcomes via openalex
- Endometriosis-Related Ovarian Cancers: Evidence for a Dichotomy in the Histogenesis of the Two Associated Histotypes via openalex
- Mesonephric-like adenocarcinoma of the ovary: features of a rare and aggressive entity associated with endometriosis via openalex
- Two possible entities of endometriosis-associated ovarian cancer: correlated or incidental? via openalex
- Use of tumor markers to distinguish endometriosis-related ovarian neoplasms from ovarian endometrioma via openalex
- W2568903712 via openalex
- W4393218578 via openalex
Source provenance
- openalex
- last seen: 2026-10-12T06:08:43.041439+00:00
License: CC0
· commercial use OK